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ABSTRACT 23 
The primary objective was to investigate whether dosing glucose by body weight results in 24 
spurious effects on measures of glucose tolerance in obese cats, because volume of 25 
distribution does not increase linearly with body weight. Healthy research cats (n = 16; 6 26 
castrated males, 10 spayed females) were used. A retrospective study was performed using 27 
glucose concentration data from glucose tolerance and insulin sensitivity tests before and 28 
after cats were fed ad libitum for 9 to 12 mo to promote weight gain. The higher dose of 29 
glucose (0.5 versus 0.3 g/kg body weight) in the glucose tolerance tests increased 2-min 30 
glucose concentrations (P <0.001), and there was a positive correlation between 2-min and 2-31 
h glucose (r = 0.65, P = 0.006).  Two-min (P = 0.016 and 0.019, respectively), and 2-h (P = 32 
0.057 and 0.003, respectively) glucose concentrations and glucose half-life (T ½) (P = 0.034 33 
and <0.001 respectively) were positively associated with body weight and body condition 34 
score (BCS). Glucose dose should be decreased by 0.05 g for every kg above ideal body 35 
weight.  Alternatively, for every unit of BCS above 5 on a 9 point scale, observed 2-h glucose 36 
concentration should be adjusted down by 0.1 mmol/L. Dosing glucose based on body weight 37 
spuriously increases glucose concentrations at 2 h in obese cats and could lead to cats being 38 
incorrectly classified as having impaired glucose tolerance. This has important implications 39 
for clinical studies assessing the effect of interventions on glucose tolerance when lean and 40 
obese cats are compared. 41 
 42 
 43 
1. Introduction 44 
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The intravenous glucose tolerance test (GTT) was introduced in human medicine in 1923 to 45 
assess glucose homestasis [1] and measures an individual’s ability to clear glucose from 46 
circulation after a bolus dose of glucose. People with impaired glucose tolerance are 47 
considered pre-diabetic and at high risk of developing type 2 diabetes [2-4]. Measures of 48 
glucose tolerance include glucose half-life (T1/2) and rate of glucose clearance (Kglucose), 49 
but these require multiple blood samples and complex mathematical calculations. In clinical 50 
practice, blood glucose concentration two hours after a standardized oral glucose dose 51 
(75g/adult person) is currently used to identify humans with impaired glucose tolerance [5,6].  52 
Approximately 1 in 200-400 domestic cats and 1 in 50 Burmese cats of European origin 53 
develop diabetes analogous to human type 2 diabetes [6-10]. As in humans, if diagnosed in 54 
the pre-diabetic state, clinical disease can likely be averted or minimized through diet and 55 
weight loss [11]. However, tests for pre-diabetes are not well characterised or commonly 56 
utilized in clinical veterinary practice, and cats are usually not diagnosed until overt diabetes 57 
is evident [8].   58 
A number of criteria for classification of glucose tolerance in cats have been published 59 
[9,12,13]. The “gold standard” test is tedious, requires multiple blood samples, and 60 
interpretation can be difficult because of the complex calculations required, such as glucose 61 
half-life, rate of glucose clearance, and area under the curve [14,15]. For many cat owners, 62 
the procedure is unacceptably expensive and invasive. A routine screening test equivalent to 63 
the test in human medicine, based on absolute glucose concentrations and requiring two 64 
blood samples, was reported in 1998 but has not been widely implemented for cats [14]. 65 
Although there are inherent problems associated with interpreting absolute glucose values 66 
[16], these measures form the basis of a satisfactory primary screening test for pre-diabetes in 67 
humans [3] and could be similarly used for cats.  68 
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In humans, oral administration of glucose has replaced intravenous administration, due to its 69 
ease and practicality [3]. Oral glucose administration has been reported in cats and, as in 70 
humans, results in greater insulin stimulation through an incretin effect [17]. However, cats 71 
are very susceptible to stress hyperglycaemia and may be stressed by oral administration 72 
which would confound the assessment of glucose tolerance [18]. Stress, particularly if it 73 
results in struggling, can increase blood glucose concentrations by as much as 10 mmol/L and 74 
take 3 h to resolve [18], and therefore needs to be avoided. Placing a cephalic catheter for 75 
glucose injection 3 h before the test start likely assists in preventing struggling and stress-76 
induced hyperglycemia during the test. 77 
A recent study in dogs reported a spurious effect on evaluation of glucose tolerance when 78 
glucose was dosed on a body weight basis in obese dogs, resulting in higher peak glucose 79 
concentrations and higher area under the glucose curve, incorrectly implying impaired 80 
glucose tolerance [19]. For the analysis of glucose tolerance, this was resolved by adjusting 81 
the measured glucose concentrations, based on peak glucose concentration. The observation 82 
that peak glucose concentration was higher in obese dogs compared to lean dogs when dosing 83 
glucose based on body weight is not surprising. For a substance injected intravenously, the 84 
volume of distribution (and circulating blood volume), expressed as a percentage of body 85 
weight, is reduced in obese individuals, because it does not increase linearly with increasing 86 
fat mass [19-21]. Therefore, when administering glucose at a dose based on body weight, 87 
obese cats are potentially overdosed in comparison with cats in ideal body condition, which 88 
could lead to a false assessment of impaired glucose tolerance. No studies investigating 89 
clearance of anaesthetic agents or sedatives or allometric scaling in cats have been identified 90 
[22]. 91 
The purpose of this study was to investigate effects of changes induced by obesity on 92 
absolute glucose concentrations measured at various times after a bolus dose of intravenous 93 
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glucose. We then determined the effect of these obesity-induced changes on assessment of 94 
glucose homeostasis, in particular, diagnosis of glucose intolerance, and investigated whether 95 
adjustment for glucose dose was indicated in obese cats. Such information is important for 96 
the development of reference values for a simple clinical test for glucose intolerance in cats 97 
that requires only a fasting and a 2-h blood sample.  98 
  99 
2. Materials and Methods 100 
A retrospective study was conducted using data from a previous study that investigated the 101 
effect of obesity on various glucose variables. That study was approved by the Animal 102 
Experimentation and Ethics Committee of the University of Queensland.  In the current 103 
study, we examined the effects of body weight and body condition on variables including 104 
peak and 2-min glucose after glucose administration, fasting glucose, glucose dose (0.3 and 105 
0.5 g/kg), and  measures of glucose tolerance such as T ½ and 2-h glucose concentration. We 106 
utilized blood glucose concentration data from glucose tolerance tests and the first 2 min 107 
from insulin sensitivity test previously performed at our laboratory in 16 cats before and after 108 
weight gain [15,23]. In the original study, 16 (10 spayed females, 6 castrated males) clinically 109 
healthy research cats between 1 and 5 yr of age (most in ideal body condition) underwent 110 
glucose tolerance and insulin sensitivity tests to provide baseline data prior to weight gain 111 
[23]. The cats were offered a combination of 2 commercially available extruded foods, with 112 
metabolizable energy consisting of 33% protein, 22.3% fat, 30.2% carbohydrate and 40% 113 
protein, 26.6% fat and 17.2 % carbohydrate, respectively [23].The tests were repeated after a 114 
weight gain period, when cats were fed ad libitum for an average (± standard deviation (SD)) 115 
of 10.5 (± 1.1 mo) (range, 9 to 12 mo) [24]. Based on dual energy x-ray absorptiometry 116 
(DEXA), after the weight gain period, all cats had more than 30% body fat (range 34.2 – 117 
48.7%) [23]. 118 
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 119 
Body condition score (BCS) was originally measured on a 5-point scale [25]. For the current 120 
study, these scores were converted to a 9-point scoring system, where scores of 1, 2, 3, 4, and 121 
5 on the 5-point scale were converted to 1, 3, 5, 7, and 9, respectively, on the 9-point scale to 122 
allow better comparison with other data sets [26]. All body condition scores were measured 123 
by the same person. 124 
 125 
In the original study, glucose tolerance and insulin sensitivity tests were performed on 126 
separate days [15]. For the glucose tolerance test, glucose was administered at 0.5 g/kg as a 127 
bolus dose over 30 s, via a jugular vein catheter. Blood samples were collected before 128 
glucose administration (four samples at -15, -10, -5, and -1 min) and after (at 2, 5, 10, 15, 30, 129 
45, 60, 90, and 120 min). For the insulin sensitivity test, glucose was administered at 0.3 g/kg 130 
as a bolus dose over 30 s, via a jugular vein catheter and insulin was injected 20 min later.  131 
Glucose concentration data before and 2 min after glucose injection in the insulin sensitivity 132 
test was used to compare the effect of glucose dose on 2-min blood glucose concentration 133 
after injection of 0.3 g/kg glucose and 0.5 g/kg  from glucose tolerance test. Data from blood 134 
samples collected after insulin administration could not be used due to effects of insulin on 135 
glucose concentrations, precluding the calculation of T ½ and time to return to baseline for 136 
the 0.3g/kg dose rate. In both tests, the timer was started halfway through infusion. Glucose 137 
was measured in plasma using an automated glucose analyser which had a precision for 138 
replicate analyses of < 2% (YSI 2300 Stat Plus; Yellow Springs Instrument Co.) [15].  139 
 140 
2.1 Statistical analyses 141 
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The statistical analyses assessed a) the effects of weight gain on 2-min and peak blood 142 
glucose concentration by comparisons before and after the 9 to 12 mo ad libitum feeding 143 
period, b) the effects of glucose dose (0.3 g/kg versus 0.5 g/kg) on 2-min glucose, and c) 144 
selected associations between fasting blood glucose concentration, 2-min and peak blood 145 
glucose concentrations, body weight, body condition score, and key measures of glucose 146 
tolerance, namely T ½ and 2-h blood glucose concentration. Linear regression and correlation 147 
coefficients were used. Statistical analyses were performed using specialist software (Stata 148 
version 12, StataCorp, College Station, Texas, USA). T ½  for glucose was estimated for each 149 
cat using glucose values from 15 to 90 min. Between these time points, the glucose 150 
disappearance curve is most rectilinear [27]. Loge (glucose) was regressed on time (in min) 151 
and T1/2 was calculated using the resulting ß-coefficient (ie. the slope coefficient) as follows: 152 
T1/2 = loge(2)/|ß-coefficient|. This was equivalent to fitting the model: Gt = G0*e(-k*t), where 153 
Gt is the serum glucose concentration at time t, and G0 is the initial serum glucose 154 
concentration based on extrapolation from the period from 15 to 90 min to time 0 [27]. 155 
For most analyses, data from before and after the ad libitum feeding period were pooled for 156 
linear regression analyses. Thus the ‘cat-period’ was the unit of analysis where each cat 157 
provided 2 'cat-periods', 1 before and 1 after it was fed ad libitum. Cat was fitted as a random 158 
effect (to account for clustering of cat-period within cat), using maximum likelihood 159 
estimation. R-square values overall and within cat were estimated using models fitted using 160 
the generalized least squares estimator. Additionally, confounding by sex of relationships 161 
assessed using linear regression was explored by comparing regression coefficients after 162 
refitting the models with sex included as a covariate; interactions with cat sex were also 163 
assessed in subsequent models. Regression coefficients changed minimally after adjustment 164 
for sex, and P - values for all interaction terms were above 0.26, so results of these additional 165 
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analyses were not reported. For correlation coefficients, 95% confidence intervals were 166 
calculated using Fisher's transformation. 167 
Following an intravenous injection of glucose at time 0, the direct causal effect of 2-min 168 
glucose concentration on 2-h glucose concentration was estimated by regressing 2-h glucose 169 
concentration on 2 - min glucose concentration with BCS fitted as a continuous covariate. 170 
The rationale for this analysis was that 2-h glucose concentration could be affected by 2-min 171 
glucose concentration via a 'direct' causal effect, if there was no (or insufficient) increase in 172 
rate of glucose clearance with higher 2-min glucose concentrations (Figure 1). Hence, higher 173 
2-min glucose concentrations would result in higher 2-h glucose concentrations. This is 174 
supported by the observation that T ½ of glucose (a measure of glucose clearance) was not 175 
closely related to peak glucose concentration (Figure 4). The rationale for fitting BCS was 176 
that BCS may affect 2-min glucose concentration if glucose dose is calculated on a body 177 
weight basis. This occurs because the volume of distribution does not increase linearly with 178 
increases in body weight due to accumulation of body fat [28]. There may also be effects of 179 
obesity on 2-h glucose concentration mediated other than through higher 2-min glucose 180 
concentration. These effects could include increases in insulin resistance with obesity, which 181 
in turn, could increase 2-h glucose concentration. If so, BCS would confound the observed 182 
association between 2-min glucose concentration and 2-h glucose concentration, when 183 
glucose is dosed on a body weight basis. Associations between fasting blood glucose and 184 
each of 2-min and 2-h blood glucose concentrations were also assessed using linear 185 
regression. Because we postulated a priori that these relationships involving fasting blood 186 
glucose may have differed between before and after the 9 to 12 mo ad libitum feeding period, 187 
separate linear regression models were fitted for each period. Variances of 2-h glucose were 188 
compared between before and after the ad libitum feeding period using Levene's test for the 189 
equality of variances between groups; this did not account for pairing of results within cat. 190 
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Reference intervals for 2-h glucose concentration were calculated using published methods 191 
[29,30] that were incorporated into a spreadsheet (Microsoft Excel spreadsheet, Reference 192 
Interval Draft Version, Copyright 2005, University of Cincinnati). Data were transformed to 193 
approximate a normal distribution using the Box-Cox transformation, and outliers identified 194 
for exclusion from subsequent calculations. Associated 90% confidence intervals (CIs) for 195 
the upper 95% limits of the reference intervals for 2-h glucose concentrations before and after 196 
the ad libitum feeding period were estimated using bootstrapping with 1000 replications. 197 
Only cats with body condition scores of 8 or 9 (n = 10) were used to calculate the reference 198 
interval after the ad libitum feeding period. 199 
 200 
3. Results  201 
After the ad libitum feeding period, the average proportional body weight increase was 44% 202 
compared to the initial body weight (before weight gain mean ± SD of 4.4 ± 0.8 kg to after 203 
weight gain 6.3 ± 1.3 kg) [20]. Most cats were initially in ideal body condition (BCS 5 n=14; 204 
BCS 3 n=1; BCS 7 n=1). Body condition scores on the 9-point scale increased from a mean ± 205 
SD of 5.0 ± 0.7 to 8.1 ± 1.1. After weight gain, 10 of the 16 cats were classed as obese (BCS 206 
8 or 9) and 6 as overweight (BCS 6 or 7). All results were based on a glucose dose of 0.5 207 
g/kg body weight IV unless otherwise stated. 208 
3.1 Effects of weight gain on 2-min and peak blood glucose concentrations 209 
When glucose dose was based on body weight (ie. 0.5 g/kg body weight), both 2-min and 210 
peak blood glucose concentrations were significantly increased by weight gain (ie. from 211 
before to after the weight gain period; P ≤ 0.001; Figure 2). Peak blood glucose 212 
concentrations occurred at 2 min for 14 of the 16 cats and at 5 min in 2 cats, both before and 213 
after the ad libitum feeding period. Peak glucose concentration was closely correlated with 2-214 
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min glucose both before and after the ad libitum feeding period (r = 0.96; 95% CI 0.88 to 215 
0.99; P < 0.001 and r = 0.98; 95% CI 0.95 to 1.00; P < 0.001, respectively).  216 
 217 
Two-minute glucose increased with each of body weight and body condition score (Table 1). 218 
Body weight explained 15% of the total variation, and 26% of the within-cat variation for 2 219 
min glucose concentrations. Body condition score explained 15% and 18% of the total and 220 
within-cat variations, respectively, for 2-min glucose concentration. 221 
 222 
3.2 Associations between peak and 2-min blood glucose concentrations and measures of 223 
glucose tolerance 224 
Before the ad libitum feeding period, both peak and 2-min glucose concentrations were 225 
positively correlated with 2-h blood glucose concentration (peak: r = 0.61; 95% CI 0.17 to 226 
0.85; P = 0.012; 2-min: r =  0.65; 95% CI 0.23 to 0.87;  P = 0.006) (Figure 3). Using pooled 227 
data from before and after the ad libitum feeding period, for every 1 mmol/L increase in 2-228 
min glucose concentration, 2-h glucose concentration increased by 0.09 mmol/L (95% CI -229 
0.01 to 0.18 mmol/L; P = 0.067). 230 
 231 
3.3 Associations between body weight and BCS and measures of glucose tolerance  232 
Using pooled data from before and after the ad libitum feeding period, 2-h glucose was 233 
associated with body weight (estimated increase for each extra kg body weight 0.33 mmol/L; 234 
95% CI -0.01 to 0.67; P = 0.057) and BCS (estimated increase for each extra unit of BCS 235 
0.32 mmol/L; 95% CI 0.11 to 0.53; P = 0.003) (Table 1, Figure 5). Body weight and BCS 236 
explained 7% and 15%, respectively, of the total variation in 2-h glucose concentrations, and 237 
30% and 38%, respectively, of the within-cat variation. The variance of 2-h glucose was 238 
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significantly larger (P = 0.013) after the ad libitum feeding period; standard deviations were 239 
0.9 mmol/L and 1.6 mmol/L before and after the ad libitum feeding period, respectively. 240 
  241 
The upper limit for the 95% reference interval for 2-h glucose concentration using cats before 242 
the ad libitum feeding period was 6.0 mmol/L (90% CI 5.1 to 6.6 mmol/L) and using cats 243 
after the ad libitum feeding period was 8.9 mmol/L (90% CI 7.1 to 9.3 mmol/L).  244 
 245 
Increasing body weight and body condition score were associated with increasing T ½(Table 246 
1). Body weight and BCS explained 9% and 19%, respectively, of the total variation in T ½, 247 
and 27% and 45%, respectively, of the within-cat variation. 248 
 249 
3.4 Association between fasting glucose and each of 2-min and 2-h glucose concentrations  250 
Both 2-min and 2-h blood glucose concentrations were positively associated with fasting 251 
blood glucose concentrations both before and after the ad libitum feeding period (P ≤ 0.018). 252 
 253 
3.5 Effect of glucose dose rate (0.3 versus 0.5 g/kg) on 2-min blood glucose concentrations 254 
The dose rate of glucose (0.3 versus 0.5 g/kg body weight) affected 2-min glucose 255 
concentrations. 2-min glucose concentration increased from a mean ± SEM of 18.0 ± 0.8 256 
mmol/L to 22.7 ± 1.3 mmol/L (P < 0.001) when glucose dose was increased from 0.3 to 0.5 257 
g/kg body weight. 2-min glucose increased by 4.7 mmol/L (95% CI 2.1 to 7.2 mmol/L) when 258 
the dose increased from 0.3 to 0.5 g/kg, equating to an increase in 2-min glucose 259 
concentration of 23.3 mmol/L for every 1g/kg increase in glucose dose. Effects of dose on T 260 
½ and 2-h blood glucose concentrations could not be calculated because insulin was 261 
administered 20 min after the 0.3 g/kg dose of glucose was given and prevented valid 262 
measurement of these variables. 263 
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 264 
3.6 Accounting for effects of obesity on 2-h glucose concentrations when using glucose 265 
tolerance tests  266 
To account for the spurious effects of obesity on 2-h glucose concentrations when dosing 267 
glucose by body weight, a number of simple theoretical options were investigated. These 268 
options were designed to allow results from cats with body condition scores varying from 269 
lean to obese to all be interpreted using the upper limit of the reference interval for 2-h 270 
glucose concentration calculated for lean cats. Two approaches were investigated: adjustment 271 
of glucose dose and adjustment of measured 2-h glucose concentration. 272 
 273 
3.6.1 Adjustment of glucose dose:  274 
For every extra unit of BCS above 5 on a 9-point scale, the glucose dose of 0.5 g/kg glucose 275 
should be reduced by 0.05 g/kg. This was calculated by the following equations: 276 
Adjusted glucose dose = Actual glucose dose - X, where X = A divided by B 277 
Where X = Adjustment of glucose dose; A = Increase in 2-min blood glucose 278 
concentration/unit BCS = 1.14 mmol/L (Table 1) and, B = Increase in 2-min glucose 279 
concentration/each 1g/kg increase in glucose dose = 23.3 mmol/L. 280 
 281 
Similarly, if using body weight as a measure, for every kg increase in body weight above the 282 
cat’s ideal body weight (its body weight if it were BCS 5), the dose should be decreased by X 283 
= 0.064 g/kg, where  284 
A = increase in 2-min blood glucose per kg increase in body weight=1.48 mmol/L (Table 1); 285 
B=23.3. 286 
 287 
 288 
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3.6.2 Adjustment of measured 2-h glucose concentration following a dose of 0.5 g/kg body 289 
weight. 290 
This was calculated as follows:  291 
Adjusted 2-h glucose concentration = actual 2-h glucose concentration – correction for obesity.  292 
The correction of 2-h glucose concentration for obesity was calculated in 3 ways, based on 293 
associations between 2-h glucose concentrations and each of 2-min glucose concentrations, 294 
BCS, and body weight from this study. These 3 methods are for use in cats with a BCS 295 
greater than 5 (method a), or when body weight is greater than ideal (ie body weight is higher 296 
than if cat were BCS 5; method b), or cats with a 2-min glucose concentration > 17.8 mmol/L 297 
(method c). 298 
3.6.2.1 Method a: Correction for obesity based on the effects of BCS on 2-min glucose 299 
concentration:  300 
 (Cat’s actual BCS – 5) x 0.10 mmol/L. 301 
This calculation assumes that 5 is an ideal BCS on a 1 to 9 scale, and 0.10 mmol/L is the 302 
direct causal amount by which 2-h glucose concentration increases for each unit increase in 303 
BCS via an effect on 2-min blood glucose concentration. This was estimated by multiplying 304 
the amount by which the 2-min glucose concentration increased per unit increase in BCS 305 
(1.14 mmol/L; Table 1) by the estimated direct causal effect of 2-min glucose concentration 306 
on 2-h glucose concentration (0.09 mmol/L). For example, one study cat had a BCS of 9 and 307 
a 2-h blood glucose concentration of 6.2 mmol/L. As this is 0.2 mmol/L above the upper limit 308 
of the calculated 95% reference interval of 6.0 mmol/L,without adjustment, this cat would 309 
have been classified as having impaired glucose tolerance. Using this method of adjustment 310 
(0.01 mmol/L for each unit of BCS), this cat would have an adjusted 2-h glucose 311 
concentration of 5.8 mmol/L (Table 2) and so be classified as having normal glucose 312 
tolerance. In contrast, another study cat with a BCS of 7 and a 2-h glucose concentration of 313 
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7.4 mmol/L would have an adjusted 2-h glucose concentration of 7.2 mmol/L, and so would 314 
still be considered to have impaired glucose tolerance.  315 
3.6.2.2. Method b: Correction for obesity based on the effects of body weight on 2-min 316 
glucose concentration:  317 
 (Cat’s actual weight – Cat’s ideal body weight) x 0.13 mmol/L,  318 
In this calculation, the amount by which the 2-min glucose concentration increased per kg 319 
increase in body weight (1.48 mmol/L; Table 1) was multiplied by the estimated direct causal 320 
effect of 2-min glucose concentration on 2-h glucose concentration (0.09 mmol/L) resulting 321 
in an adjustment of 2-h blood glucose by 0.13mmol/L per kg of weight increase from ideal 322 
body weight (Table 2).  323 
3.6.2.3 Method c: Correction for obesity based on the mean 2-min glucose concentration in 324 
cats of ideal BCS (BCS 5) 325 
(Cat’s actual 2-min glucose concentration – 17.8) x 0.09 in mmol/L. 326 
In this calculation, 17.8 mmol/L was used as this was the mean 2-min glucose concentration 327 
for cats with ideal BCS (BCS 5; n=14 cats prior to the ad libitum feeding period), and 0.09 is 328 
the estimated direct causal effect of 2-min glucose concentration on 2-h glucose 329 
concentration. This method assumes that the 2-min glucose concentration for cats in ideal 330 
BCS (5) is always 17.8 mmol/L. For the cat in the previous example with a BCS of 9, the 2-331 
min glucose concentration was 29.2 and the recalculated 2-h glucose concentration was 5.3 332 
mmol/L. Similarly, for the cat with a BCS of 7, the 2-min glucose concentration was 21.7 333 
mmol/L, and the recalculated value of 7 mmol/L would still be considered indicative of 334 
impaired glucose tolerance (Table 2). 335 
 336 
4. Discussion  337 
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Glucose clearance after an intravenous glucose challenge, and therefore measured glucose 338 
concentrations, are influenced by complex mechanisms involving insulin and non-insulin 339 
dependent glucose uptake into tissues, as well as suppression of glucose output via 340 
gluconeogenesis in the liver [31]. Obesity affects both receptor and post-receptor processes 341 
involved in glucose uptake into tissues, and inhibits suppression of hepatic gluconeogenesis. 342 
Obesity also adversely affects beta cell function and insulin secretion [32]. These effects on 343 
glucose clearance are mediated by insulin resistance as well as other direct effects including 344 
inflammatory mediators associated with obesity [16].  345 
Glucose tolerance is assessed by measures of glucose clearance such as glucose half-life (T 346 
½), and absolute glucose concentrations at a given time after a glucose challenge, for 347 
example, 2 h [33]. In cats, glucose is most commonly administered intravenously and dosed 348 
on a body weight basis [12,16]. However, the volume of distribution of glucose does not 349 
increase linearly with increasing fat mass, potentially resulting in a relative glucose overdose 350 
in obese cats. Our study is the first study to examine whether dosing glucose on a per kg basis 351 
in an intravenous glucose tolerance test has a spurious effect on the results when testing 352 
overweight and obese cats. There were several important findings from this study that clinical 353 
researchers should be aware of when comparing glucose tolerance between lean and obese 354 
cats. 355 
Firstly, glucose concentration measured at 2 min is positively associated with glucose dose. 356 
Secondly, the 2-min glucose concentration has a direct causal effect on the 2-h glucose 357 
concentration. Thirdly, both body condition score and body weight were positively associated 358 
with 2-min and peak glucose concentrations, 2-h glucose concentration, and T ½ . These 359 
findings corroborate those of others [12,16] and have implications for interpreting measures 360 
of glucose tolerance, especially glucose concentrations at 2 h after glucose administration. 361 
There is the potential to erroneously classify an obese cat as having impaired glucose 362 
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tolerance because of the effect of a standard glucose dose on peak or 2-min glucose, and 363 
subsequently on 2-h glucose concentration. 364 
Peak (and 2-min) glucose concentration are a reflection of the volume of distribution, as no 365 
substantial clearance of glucose from the blood occurs in the short timeframe [16,21]. The 366 
volume of distribution, that is the circulating blood volume, does not increase linearly with 367 
body weight in obesity [34,35]. The important finding in our study is that there is relative 368 
overdosing of glucose in obese cats when glucose dosing is based on body weight. Further 369 
investigation would be required to examine if dosing on ideal body weight or using a fixed 370 
dose regardless of body weight, as used in human medicine, was advantageous in glucose 371 
tolerance tests in obese cats. Both of these methodologies incorrectly assume that volume of 372 
distribution (circulating blood volume) do not increase concomitant with increasing fat mass. 373 
However blood volume indeed does increase with increasing fat mass, but at a proportionally 374 
lower rate compared to if the weight increase was muscle [24]. The second limitation with 375 
dosing based on ideal body is the inherent imprecision of estimating ideal body weight in 376 
obese cats using morphometric or other measures available in clinical practice.  377 
 378 
In human [3,4,36] and veterinary [8] medicine, fasting glucose concentration is also used as a 379 
measure of glucose homeostasis, and patients with increased concentrations are classified as 380 
either having impaired fasting glucose or diabetes, depending on the magnitude of the 381 
increase. Fasting glucose concentration is less sensitive for detecting abnormalities of glucose 382 
homeostasis than measurement of glucose concentrations after a glucose challenge, as occurs 383 
in the glucose tolerance test [2,37,38]. T ½  is based on 4 glucose measurements from 15-90 384 
min and there was no evidence that T ½ was affected substantially by peak values.  Whether 385 
it is a better tool to assess glucose tolerance status in obese cats, or is a less sensitive measure 386 
of glucose tolerance than absolute glucose concentrations is unclear. However, it is 387 
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technically more difficult to calculate and not suitable as a simple measure of glucose 388 
tolerance status for use in clinical research or veterinary practice. In clinical practice in 389 
humans, the 2-h glucose concentration has replaced T1/2 as a measure to identify individuals 390 
with impaired glucose tolerance and diabetes.   391 
It is important to separate the dosage effect of obesity from the pathological effect of obesity 392 
on the 2-h glucose concentration. The pathological effect is associated with impaired glucose 393 
clearance from the circulating blood as a result of peripheral insulin resistance secondary to 394 
obesity and a number of other factors affecting glucose uptake into tissues and insulin 395 
secretion [11]. In our study, the combined dosage and pathological effects increased the 2-h 396 
glucose concentration by 0.32 mmol/L for every unit increase in body condition score. The 397 
calculated spurious effect of dosing on body weight was 0.10 mmol/L/unit increase in BCS, 398 
or approximately 30% of the overall increase in 2-h blood glucose induced by obesity. Our 399 
results showed a significant difference between the upper 95% reference interval for 2-h 400 
glucose concentrations in lean and obese cats (6 and 8.9 mmol/L), indicating that one 401 
reference limit for all cats was inappropriate. However, employing different reference limits 402 
for different body condition scores or body weights could cause confusion and be less 403 
practical. Based on our results, a simplified test for assessment of glucose tolerance—relying 404 
on a 2-h blood glucose measurement and a single reference range for normal cats—would 405 
need to account for the dosage effects of obesity. This could be achieved in overweight and 406 
obese cats by adjusting down either the dose of glucose administered, or the 2-h glucose 407 
value before interpretation with standardised reference limits. 408 
Based on the associations found, we propose two ways to adjust the measured 2-h glucose 409 
value, to account for the dosage effects of obesity. Both methods attempt to account for the 410 
effects of dose alone, and therefore involve the relationships between body weight or 411 
condition, 2-min, and 2-h glucose concentrations. The direct causal effect (spurious effect) of 412 
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2-min glucose concentration on 2-h glucose concentration was estimated by regressing 2-h 413 
glucose concentration on 2-min glucose concentration adjusted for BCS. Thus, our estimates 414 
of this relationship are independent of any decrease in insulin sensitivity in the obese cats. 415 
Adjustment using measured 2-min glucose is considered less ideal than using BCS because it 416 
relies on comparison with the calculated mean 2-min glucose concentration for lean cats, 417 
which may cause inaccuracies given that the standard deviation for the 2-min glucose 418 
concentration was relatively large. Also, this method requires a third blood sample, which 419 
would decrease the simplicity of the test, and would be more technically difficult than 420 
measurement of the fasting and 2-h samples because of the small leeway with timing. 421 
The preferred option is using BCS to adjust 2-h glucose based on the observed effect of BCS 422 
on 2-min glucose (method a), because it is likely to provide a reasonably accurate adjustment 423 
for 2-h glucose concentrations. Although there is some error in measuring BCS, an error of 1-424 
2 BCS units would only affect the adjusted 2-h glucose concentration by 0.10-0.2 mmol/L. 425 
Body weight is a more quantitative measure of the size of the cat than body condition score, 426 
however, the latter provides a better estimate of the extent of obesity, and had a bigger effect 427 
on many of the measured associations. Adjustments based on body weight would require 428 
knowledge of the cat’s previous ideal weight, or subjective assessment of each obese cat’s 429 
ideal weight, and this might be less accurate than an assessment of body condition score. 430 
However, adjustment on body weight could be useful in research or clinical practice where 431 
the actual increase in body weight above normal was known, or morphometric measures were 432 
used to calculate ideal body weight [39,40]. The alternative strategy proposed is to adjust the 433 
dose rate, with the aim of reducing the peak glucose concentration in obese cats to the same 434 
or similar to that in lean cats. This theoretical approach to calculation of the reduced dose rate 435 
needs to be confirmed through an empirical study to identify the correct dose rate for 436 
different body condition scores in cats. The calculations used were theoretical and several 437 
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assumptions were made, but regardless of these limitations, the spurious effect is likely small, 438 
particularly in relation to the magnitude of the precision error, and only of concern in an 439 
obese cat that is close to the cutpoint. 440 
Our study has provided an important foundation for the development of a feline equivalent to 441 
the human GTT for identifying glucose intolerance in cats. The feline test includes glucose 442 
being administered intravenously, but would require only 2 blood samples, and would 443 
provide clinical researchers and veterinary practitioners with a practical screening tool for 444 
pre-diabetes in cats. We propose that a standard reference range for 2-h glucose be developed 445 
to interpret GTT results for cats of all body condition scores, and this range should be 446 
determined from cats with ideal BCS (4 and 5). Testing of overweight and obese cats would 447 
then require an adjustment to compensate for the ‘dosage’ effects of obesity, following 448 
guidelines outlined in this research. 449 
The main limitations in this study are related to the fact that the study population was young 450 
adult cats less than 4 years of age, whereas glucose tolerance testing to identify pre-diabetic 451 
cats will have most use in senior cats because of the age predisposition to diabetes in this 452 
species. It is recommended that a longer fasting period before testing be used  if cats are fed 453 
once a day with a high carbohydrate diet (50% of energy), because blood glucose 454 
concentrations may take 24 h to return to baseline in some cats [41]. Withholding food for 14 455 
h is sufficient for 75% of cats fed twice daily a high carbohydrate diet [42]. 456 
In conclusion, dosing obese cats based on body weight spuriously affects some measures of 457 
glucose tolerance in a glucose tolerance test, and could lead to cats being incorrectly 458 
classified as having impaired glucose tolerance. For an individual cat, the dosing effect is 459 
relatively small, and only of concern if 2-h blood glucose concentration is just above the 460 
upper cutpoint of the reference range – the maximum expected increase in 2-h glucose 461 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
concentration is 0.4 mmol/L for obese cats (BCS 9 on a 1 - 9 scale). However, it has 462 
important implications for clinical studies assessing the effect of interventions such as diet or 463 
medication on glucose tolerance, if glucose concentrations are compared between lean and 464 
obese cats. This dosing effect may be accounted for in overweight and obese cats by 465 
adjusting down either the dose of glucose administered by 0.05 g for every kg increase above 466 
ideal weight, or the measured 2-h glucose value by 0.1 mmol/L for every unit of BCS 467 
increase above 5 on a 9 point scale, before interpretation with standardised reference limits.  468 
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Tables 603 
Table 1 Regression coefficients, 95% confidence intervals and  P- values for the associations 604 
between body weight and body condition score and peak, 2-min, and 2-h blood glucose 605 
concentrations,  and half life (T ½) following glucose bolus of 0.5 g/kg body weight for 16 606 
healthy cats assessed before and after a 9 to 12 mo ad libitum feeding period. 607 
Variables Peak blood 
glucose 
2-min blood 
glucose 
T ½  2-h blood 
glucose 
Body weight For every extra 
kg body weight, 
the estimated 
increase was 
1.50 mmol/L 
(95% CI 0.40 to 
2.61; P = 0.008). 
For every extra 
kg body weight, 
the estimated 
increase was 
1.48 mmol/L 
(95% CI 0.27 to 
2.69; P = 0.016) 
For every extra 
kg of body 
weight, T ½ 
increases by 5.5 
mins (95% CI 
0.4 to 10.6; P = 
0.034). 
For every extra 
kg body weight, 
the estimated 
increase was 
0.33 mmol/L 
(95% CI -0.01 to 
0.67; P = 0.057) 
Body condition 
score (BCS) 
For every extra 
unit of BCS, the 
estimated 
increase was 
1.06 mmol/L   
(95% CI 0.18 to 
1.94; P = 0.018) 
For every extra 
unit of BCS the 
estimated 
increase was 
1.14 mmol/L 
(95% CI 0.19 to 
2.09; P = 0.019). 
For every extra 
unit of BCS, T 
½ increases by 
5.6 mins (95% 
CI 2.5 to 8.8; P 
< 0.001) 
For every extra 
unit of BCS, the 
estimated 
increase was 
0.32 mmol/L  
(95% CI 0.11 to 
0.53; P = 0.003). 
 608 
 609 
 610 
 611 
 612 
 613 
 614 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
27 
 
Table 2: Body condition scores (BCS), fasting blood glucose concentrations, T ½ values, and 615 
measured and adjusted 2-h blood glucose concentrations after a 9 to 12 mo ad libitum feeding 616 
period in 16 cats. Cats with suspected glucose intolerance based on T ½ values are bolded.  617 
Cat BCS 
Fasting blood 
glucose 
concentration 
mmol/L 
T ½ after 
weight gain 
(upper limit 
of normal 
reported as 
74[15] and 
95[7] min) 
Measured 
2-h blood 
glucose 
mmol/L  
Upper 
limit 6.0 
mmol/L  
Adjusted  
2-h blood 
glucose 
mmol/L  
using 
method a*  
Adjusted 
2-h blood 
glucose 
mmol/L  
using 
method 
b*  
Adjusted 
2-h blood 
glucose 
mmol/L  
using 
method 
c*  
1 9 5.0  105.67 5.7  5.3  5.4 3.6  
2 9 3  60.11 4.0  3.6  3.6 4  
3 9 4.4  40.31 3.2  2.9  2.9 2.4  
4 9 4.1 46.94 3.8  3.5  3.6 3.2  
5 6 3.9  54.57 3.1  3.1  3.1 2  
6 9 3.9  77.14 6.7  6.4  6.3 5.7  
7 9 4.6  57.63 2.7  2.4  2.5 2.7  
8 7 2.2  46.17 3.2  3.0  2.9 2.5  
9 7 3.9  116.78 7.4  7.2  7.3 7  
10 8 4.3  96.08 6.0  5.7  5.7 6.4  
11 7 3.5  69.2 4.4  4.2  4.2 4.1  
12 7 4.8  93.78 6.5  6.3  6.4 5.8  
13 7 4.6  70.41 4.1  3.9  3.8 3.6  
14 9 4.5  88.99 6.2  5.8  6.0 5.6  
15 9 5.0 62.16 4.5  4.1  4.1 4.6  
16 8 4.6  59.79 2.5  2.2  2.2 2.8  
 618 
a*(Cat’s actual BCS – 5) x 0.10 mmol/L. 619 
b* (Cat’s actual weight – Cat’s ideal weight) x 0.13 mmol/L 620 
c*(Cat’s actual 2-min glucose concentration – 17.8) x 0.09 mmol/L 621 
 622 
 623 
  624 
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Figure Legends 625 
Figure 1: Causal diagram showing interrelationships between obesity and 2-min and 2-h 626 
blood glucose concentrations in cats undergoing a glucose tolerance test.  627 
Figure 2: Associations between 2-min blood glucose concentration following an intravenous 628 
glucose infusion (dosed at 0.5 g/kg body weight) and each of body weight (A) (estimated 629 
increase for each extra kg body weight 0.14 mmol/L; 95% CI 0.27 to 2.69; P = 0.016) and 630 
body condition score (B) (estimated increase for each extra unit of BCS 0.14 mmol/L; 95% 631 
CI 0.19 to 2.09; P = 0.019) in 16 healthy cats assessed before (circles) and after (triangles) 632 
approximately 10 mo of ad lib feeding. Lines are least squares lines of best fit. 633 
Figure 3: Association between 2-h blood glucose concentration following an intravenous 634 
glucose infusion (dosed at 0.5 g/kg body weight) and each of 2-min blood glucose (A)(r = 635 
0.65; 95% CI 0.23 to 0.87; P = 0.006) and peak blood glucose (B) (r = 0.61; 95% CI 0.17 to 636 
0.85; P = 0.012) concentrations in 16 healthy lean cats. Lines are least squares lines of best 637 
fit. 638 
Figure 4: Association between T ½ for glucose disappearance following an intravenous 639 
glucose infusion (dosed at 0.5 g/kg body weight) and each of 2-min blood glucose (A) (r = 640 
0.17; 95% CI -0.35 to 0.62; P = 0.518) and peak blood glucose (B) (r = 0.18; 95% CI -0.34 to 641 
0.62; P = 0.498) concentrations in 16 healthy lean cats. Lines are least squares lines of best 642 
fit. 643 
Figure 5: Association between 2-h blood glucose concentration following an intravenous 644 
glucose infusion (dosed at 0.5 g/kg body weight) and each of body weight (A) (estimated 645 
increase for each extra kg body weight 0.33 mmol/L; 95% CI -0.01 to 0.67; P = 0.057) and 646 
body condition score (B) (estimated increase for each extra unit of BCS 0.32 mmol/L; 95% 647 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
29 
 
CI 0.1 to 0.5; P = 0.003) in 16 healthy lean cats assessed before (circles) and after (triangles) 648 
approximately 10 mo of ad libitum feeding. Lines are least squares lines of best fit.  649 
 650 
 651 
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2-min blood 
glucose 
2-h blood glucose 
 
 
Obesity 
Direct causal effect 
of 2-min glucose on 
2-h glucose:  higher 
peak (and 2-min) 
glucose  leads to 
higher 2-h glucose.  
Indirect effect of obesity on 2-h glucose 
concentration due to dosing based on body 
weight regardless of body condition score. 
 
Direct pathological effect of 
obesity on 2-h glucose 
concentration via reduced 
insulin sensitivity and other 
mechanisms. 
Effect of obesity on 
2-min glucose due to 
dosing based on 
body weight 
regardless of body 
condition score. 
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DAE-15-176R1 Highlights 
 
• This study investigated if dosing glucose by bodyweight results in spurious effects on 
measures of glucose tolerance in obese cats, because volume of distribution does not 
increase linearly with bodyweight.   
• Retrospective analysis of glucose concentrations from glucose tolerance and insulin 
sensitivity tests before and after 16 cats were fed ad libitum 9 - 12 mo to promote 
weight gain. 
• Bodyweight and body condition score (BCS) were positively correlated with 2-min, 
2-h glucose concentrations following a glucose tolerance test and glucose half-life. 
• Equations were developed to adjust either glucose dose or 2-h glucose to compensate 
for the dosage effects of obesity. 
 
